[1] 中国内分泌代谢病专科联盟.甲状腺结节诊治行业标准[J].中华内分泌代谢杂志,2022,38(7):552-554. [2] KUO J H,MCMANUS C,LEE J A.Analyzing the adoption of radiofrequency ablation of thyroid nodules using the diffusion of innovations theory:understanding where we are in the United States?[J].Ultrasonography,2022,41(1):25-33. [3] LI Y,JIN C,LI J,et al.Prevalence of thyroid nodules in China:A health examination cohort-based study[J].Front Endocrinol,2021,12:676144. [4] 李彦娟,王磊,王钰,等.甲状腺结节发病率调查及影响因素分析[J].中国综合临床,2020,36(5):455-459. [5] SU Y,ZHANG Y,ZHAO M,et al.Association between thyroid nodules and volume and metabolic syndrome in an iodine-adequate area:A large community-based population study[J].Metab Syndr Relat Disord,2019,17(4):217-222. [6] 齐力. 中国成为全球消费电子和家用电器重要制造基地[J].中国对外贸易,2024(2):72-73. [7] GALAVIZ K I,WEBER M B,STRAUS A,et al.Global diabetes prevention interventions:A systematic review and network meta-analysis of the real-world impact on incidence,weight,and glucose[J].Diabetes Care,2018,41(7):1526-1534. [8] 中国老年2型糖尿病防治临床指南编写组,中国老年医学学会老年内分泌代谢分会,中国老年保健医学研究会老年内分泌与代谢分会,等.中国老年2型糖尿病防治临床指南(2022年版)[J].中华内科杂志,2022,61:39. [9] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409. [10] 中华医学会,中华医学杂志社,中华医学会全科医学分会,等.高血压基层诊疗指南(2019年)[J].中华全科医师杂志,2019,18(4):301-313. [11] 中国血脂管理指南修订联合专家委员会.中国血脂管理指南(2023年)[J].中国循环杂志,2023,38(3):237-271. [12] 陈晓韵,徐明彤,林刁珠,等.40岁以上人群甲状腺结节与代谢指标之间的关联性[J].中山大学学报(医学版),2018,39(3):369-376. [13] 刘雅思,张先翠,谢郁芳,等.不同BMI职业健康检查人群甲状腺结节检出情况和影响因素分析[J].齐齐哈尔医学院学报,2023,44(10):972-978. [14] 赖晓英,欧阳平,朱宏,等.甲状腺结节检出情况及影响因素:10年309 576例职业健康检查人群分析[J].南方医科大学学报,2020,40(2):268-273. [15] DUBLIN J C,PAPAZIAN M,ZAN E,et al.Predictive value of a genomic classifier in indeterminate thyroid nodules based on nodule size[J].JAMA Otolaryngol Head Neck Surg,2022,148(1):53-60. [16] 留碧丽,夏文霞,李敏,等.超声检查及引导穿刺活检在甲状腺微小结节良恶性中的鉴别诊断价值[J].医学影像学杂志,2021,31(11):1864-1867. [17] MOON J H,HYUN MK,LEE J Y,et al.Prevalence of thyroid nodules and their associated clinical parameters:A large-scale,multicenter-based health checkup study[J].Korean J Intern Med,2018,33(4):753-762. [18] CHEN Y,ZHU C,CHEN Y,et al.The association of thyroid nodules with metabolic status:A cross-sectional SPECT-China study[J].Int J Endocrinol,2018,2018:6853617. [19] LIANG Q,YU S,CHEN S,et al.Association of changes in metabolic syndrome status with the incidence of thyroid nodules:A prospective study in Chinese adults[J].Front Endocrinol(Lausanne),2020,11:582. [20] XU L,ZENG F,WANG Y,et al.Prevalence and associated metabolic factors for thyroid nodules:A cross-sectional study in southwest of China with more than 120 thousand populations[J].BMC Endocr Disord,2021,21(1):175. [21] OSPINA N S,PAPALEONTIOU M.Thyroid nodule evaluation and management in older adults:A review of practical considerations for clinical endocrinologists[J].Endocr Pract,2021,27(3):261-268. [22] ZHANG C,GAO X,HAN Y,et al.Correlation between thyroid nodulesand metabolic syndrome:a systematic review and Meta-analysis[J].Front Endocrinol(Lausanne),2021,12:730279. [23] 阮小风,张建军,夏红梅,等.非酒精性脂肪性肝病与甲状腺结节异病同治理论探析[J].中西医结合肝病杂志,2021,31(1):81-82,89. [24] PIANTANIDA E,IPPOLITO S,GALLO D,et al.The interplay between thyroid and liver:Implications for clinical practice[J].Endocrinol Invest,2020,43(7):885-899. [25] 姚宏,胡艳,饶开晴,等.雌激素-雌激素受体通路影响母鸡脂肪肝发生的可能机制[J].动物营养学报,2021,33(1):85-94. [26] SADEGHI H,JAHANBAZI F,SADEGHI H,et al.Metformin attenuates oxidative stress and liver damage after bile duct ligation in rats[J].Res Pharm Sci,2019,14(2):122-129. |